- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelioid Sarcoma—From Genetics to Clinical Practice
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2112
Publisher
MDPI AG
Online
2020-07-30
DOI
10.3390/cancers12082112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epitheliod sarcoma: Molecular insights into proximal versus classic variant.
- (2020) Anna Maria Frezza et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase Ib/III randomized, double-blind, placebo-controlled study of tazemetostat plus doxorubicin as frontline therapy for patients with advanced epithelioid sarcoma.
- (2020) Shiraj Sen et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy, safety, and immune priming effect of tazemetostat in patients with epithelioid sarcoma.
- (2020) Mrinal M. Gounder et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials
- (2019) Sheri L. Spunt et al. EUROPEAN JOURNAL OF CANCER
- Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry
- (2019) Monika Sparber-Sauer et al. PEDIATRIC BLOOD & CANCER
- Epithelioid sarcoma: half a century later
- (2019) Samer T. Elsamna et al. ACTA ONCOLOGICA
- A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
- (2019) Sheri L Spunt et al. LANCET ONCOLOGY
- Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
- (2019) Birgit Geoerger et al. LANCET ONCOLOGY
- Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2018) P G Casali et al. ANNALS OF ONCOLOGY
- European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy
- (2018) N. Touati et al. CLINICAL ONCOLOGY
- Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma
- (2018) Emily Z. Keung et al. EJSO
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma
- (2018) Anna Maria Frezza et al. JAMA Oncology
- Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis
- (2017) Hidetatsu Outani et al. International Journal of Clinical Oncology
- Management and potentialities of primary cancer cultures in preclinical and translational studies
- (2017) Giacomo Miserocchi et al. Journal of Translational Medicine
- The potential of emerging therapeutics for epithelioid sarcoma
- (2017) Brittany L. Siontis et al. Expert Opinion on Orphan Drugs
- Myxofibrosarcoma primary cultures: molecular and pharmacological profile
- (2017) Alessandro De Vita et al. Therapeutic Advances in Medical Oncology
- Epithelioid Sarcoma
- (2016) Khin Thway et al. ADVANCES IN ANATOMIC PATHOLOGY
- Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
- (2016) Scott M. Schuetze et al. CANCER
- The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study
- (2016) Tomoki Nakamura et al. CANCER
- Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
- (2016) Antoine Italiano PHARMACOLOGY & THERAPEUTICS
- Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies
- (2016) Rick L.M. Haas et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients
- (2015) Naofumi Asano et al. ANNALS OF SURGICAL ONCOLOGY
- HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components
- (2015) G. Lopez et al. MOLECULAR CANCER RESEARCH
- Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
- (2015) Jonathan Noujaim et al. Frontiers in Oncology
- Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
- (2014) Yoshinori Imura et al. Molecular Cancer
- Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
- (2014) Daniel Pink et al. ONCOLOGY
- Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread--results of a large prospective trial
- (2013) D. Andreou et al. ANNALS OF ONCOLOGY
- Epithelioid Sarcoma: Need for a Multimodal Approach to Maximize the Chances of Curative Conservative Treatment
- (2013) Antonin Levy et al. ANNALS OF SURGICAL ONCOLOGY
- ERG and FLI1 protein expression in epithelioid sarcoma
- (2013) David L Stockman et al. MODERN PATHOLOGY
- SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
- (2013) M. Brenca et al. MOLECULAR CANCER THERAPEUTICS
- Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis
- (2013) J Darr et al. ONCOGENE
- High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
- (2013) Makoto Emori et al. PLoS One
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate
- (2012) P. Penot et al. BRITISH JOURNAL OF DERMATOLOGY
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- Epithelioid sarcoma: one institution's experience with a rare sarcoma
- (2012) Angela A. Guzzetta et al. JOURNAL OF SURGICAL RESEARCH
- A retrospective study of SBRT of metastases in patients with primary sarcoma
- (2012) Christina Linder Stragliotto et al. MEDICAL ONCOLOGY
- SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma
- (2012) Gergő Papp et al. MODERN PATHOLOGY
- Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
- (2012) Lisa M Sullivan et al. MODERN PATHOLOGY
- Role of Palliative Chemotherapy in Advanced Epithelioid Sarcoma
- (2011) Robin L. Jones et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Reirradiation and hyperthermia for radiation-associated sarcoma
- (2011) Marianne A. A. de Jong et al. CANCER
- Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma
- (2011) Xianbiao Xie et al. CLINICAL CANCER RESEARCH
- E-Cadherin/β-Catenin Complex and the Epithelial Barrier
- (2011) Xinrui Tian et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Epithelioid Sarcoma and Unclassified Sarcoma with Epithelioid Features: Clinicopathological Variables, Molecular Markers, and a New Experimental Model
- (2011) A. Sakharpe et al. ONCOLOGIST
- A Case Report of Complete Remission of Pulmonary Metastases From Epithelioid Sarcoma to Navelbine Chemotherapy
- (2010) Zeeshan Tariq et al. AMERICAN JOURNAL OF THERAPEUTICS
- Prognostic determinants in epithelioid sarcoma
- (2010) Patrizia Gasparini et al. EUROPEAN JOURNAL OF CANCER
- Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare
- (2010) Michael J Cascio et al. MODERN PATHOLOGY
- Epithelioid Sarcoma
- (2009) Laila Chbani et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma
- (2009) Jason L. Hornick et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas
- (2009) Ugwuji N. Maduekwe et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER Database
- (2009) Muhammad Umar Jawad et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma
- (2009) Makiko Hoshino et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Epithelioid sarcoma: the University of Washington experience
- (2008) Patrick S. Wolf et al. AMERICAN JOURNAL OF SURGERY
- Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor
- (2008) Kenichi Kohashi et al. HUMAN PATHOLOGY
- Lymph node metastases in soft tissue sarcomas—a single center analysis of 1,597 patients
- (2008) A. Daigeler et al. LANGENBECKS ARCHIVES OF SURGERY
- Clinicopathological features with outcomes of a series of conventional and proximal-type epithelioid sarcomas, diagnosed over a period of 10 years at a tertiary cancer hospital in India
- (2008) Bharat Rekhi et al. VIRCHOWS ARCHIV
- Epithelioid sarcoma with muscle metastasis detected by positron emission tomography
- (2008) Akio Sakamoto et al. World Journal of Surgical Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More